In collaboration with Payame Noor University and Iranian Society of Physiology and Pharmacology

Document Type : Article

Author

Department of biology, Payame ‎Noor University, Tehran, Iran

10.30473/eab.2023.68023.1910

Abstract

Oxymetholone is a 17-alpha- alkamine and a synthetic derivative of testosterone, which is obtained through the methylation of the 17-alpha carbon and the saturation of the 5-alpha carbon of testosterone. Oxymetholone is an anabolic-androgenic steroid which is used for the treatment of  anemia caused by severe bone marrow weakness and the prevention of the consequences of hereditary angioedema or the treatment of growth delay which of course is used in bodybuilding to increase muscle volume and strength. Considering the harmful effects on this drug on the body, we decided to determine the effects of oxymetholone on the oogenesis of NMRI mice. For this, was injected(12mg/kg/day) interaperitoneally to mice in 6 and 4 weeks age in one  periods of 35 days. The results showed that the significant difference between treatment and control groups was observed( P<0.05). This teratogenic effects involved: decrese in ovarian weight, decrese in ovarian diameter, decrese in number of Corpuse luteum, increase of primordial follicles, decrese of primary follicles, decrese of growing follicles, decrese of graaf follicles, decrese in number of atretic follicle, decrese of granolosa layer diameter and decrese in progestron. Additionally in some experimental case, the disorder in formation of granolosa layers and don’t formation of corna radiate layers, disordering of ovule medulla and formation of two oocyte in one follicle were observed. The results showed that the use of this drug in the experimental group will have a negative effect on ovarian growth and ovulation.

Keywords

Main Subjects

Achar, S., Rostamian, A., & Narayan, S. M. (2010). Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. The American journal of cardiology, 106(6), 893-901.
Bahmani M, Yusefi-jurdehi A, Halajian E, Poordehghani M, Moradi Y, & Mosadegh M. (2017). Residual levels of hormones in oocyte of Acipenser percicus and Acipenser baerii Aquaculture Development journal, 10(2), 41-47 (in Persian).
Basaria, S., Wahlstrom, J. T., & Dobs, A. S. (2001). Anabolic-androgenic steroid therapy in the treatment of chronic diseases. The Journal of Clinical Endocrinology & Metabolism, 86(11), 5108-5117.
Christiansen, K. (2001). Behavioural effects of androgen in men and women. The Journal of endocrinology, 170(1), 39-48.
Collaer, M. L., & Hines, M. (1995). Human behavioral sex differences: a role for gonadal hormones during early development? Psychological bulletin, 118(1), 55.
El-Desoky, E.-S. I., Reyad, M., Afsah, E. M., & Dawidar, A.-A. M. (2016). Synthesis and chemical reactions of the steroidal hormone 17α-methyltestosterone. Steroids, 105, 68-95.
Fredrigue, Z. (2001). Williem Den Besten, Bo Chen, Jerold E, Esther L. Control of Spermatogenesis in Mice by the Cyclin D-Dependent Kinase Inhibitors P18Ink42 and P19Ink4d. Molecular and Cellular Boilogy, 21(9), 3244-3255.
Giorgi, A., Weatherby, R. P., & Murphy, P. W. (1999). Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study. Journal of Science and Medicine in Sport, 2(4), 341-355.
Jänne, O. A., Palvimo, J. J., Kallio, P., & Mehto, M. (1993). Androgen receptor and mechanism of androgen action. Annals of medicine, 25(1), 83-89.
Karila, T., Karjalainen, J., Mäntysaari, M., Viitasalo, M., & Seppälä, T. (2003). Anabolic androgenic steroids produce dose-dependent increase in left ventricular mass in power athletes, and this effect is potentiated by concomitant use of growth hormone. International journal of sports medicine, 24(05), 343-373.
Khajvand, N. (2011). Anabolic steroids and nutritional supplements in sport: Tehran: Bamdad.
Lundholm, L., Käll, K., Wallin, S., & Thiblin, I. (2010). Use of anabolic androgenic steroids in substance abusers arrested for crime. Drug and alcohol dependence, 111(3), 222-226.
Masse, R., & Bi, H. (1992). Studies on anabolic steroids, GC/MS, Characterization of unusual seco acidic methabolites of oxymetholone in human urin. J Steroid Biochem Mol Biol, 42(2), 222-242.
Mooradian, A. D., Morley, J. E., & Korenman, S. G. (1987). Biological actions of androgens. Endocrine reviews, 8(1), 1-28.
Murray, R. K., Granner, D. K., Mayes, P. A., & Rodwell, V. W. (2003). Harper’s illustrated biochemistry.
Saudan, C., Baume, N., Robinson, N., Avois, L., Mangin, P., & Saugy, M. (2006). Testosterone and doping control. British journal of sports medicine, 40(suppl 1), i21-i24.
Shahidi, N., & Clatanoff, D. (1969). The Role of Puberty in Red‐Cell Production in Hereditary: Haemolytic Anaemias. British Journal of Haematology, 17(4), 335-342.
Shahidi, N. T. (2001). A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clinical therapeutics, 23(9), 1355-1390.
Svare, B. B. (1976). A Preclinical Research Prospectus. NIDA Research Monograph, 102, 224.
Naji, T. Bagheri ziary, s., Hoseinzade Sahafi, E. (2016). Effect of 17 beta steradiol and LHRH-A and extract of Origanum vulgare. Aquaculture Development journal, 9(3), 59-69 (in Persian).
Wiefferink, C., Detmar, S., Coumans, B., Vogels, T., & Paulussen, T. (2008). Social psychological determinants of the use of performance-enhancing drugs by gym users. Health education research, 23(1), 70-80.
Wilson, J. M. (1996). Adenoviruses as gene-delivery vehicles. New England Journal of Medicine, 334(18), 1185-1187.
WorldAntidopingAgency. (2002).   Retrieved from www.wada-ama.com.
Wright, J. E. (1980). Anabolic steroids and athletics. Exercise and sport sciences reviews, 8(1), 149.